DE10290563D2 - Mittel zur Hemmung von Tumorzellen - Google Patents

Mittel zur Hemmung von Tumorzellen

Info

Publication number
DE10290563D2
DE10290563D2 DE10290563T DE10290563T DE10290563D2 DE 10290563 D2 DE10290563 D2 DE 10290563D2 DE 10290563 T DE10290563 T DE 10290563T DE 10290563 T DE10290563 T DE 10290563T DE 10290563 D2 DE10290563 D2 DE 10290563D2
Authority
DE
Germany
Prior art keywords
tumor cell
cell inhibitor
inhibitor
tumor
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10290563T
Other languages
English (en)
Inventor
Robert Preissner
Wolfgang Dubiell
Audrean Goede
Cornelius Froemmel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charite Universitaetsmedizin Berlin
Original Assignee
Universitatsklinikum Charite Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatsklinikum Charite Berlin filed Critical Universitatsklinikum Charite Berlin
Priority to DE10290563T priority Critical patent/DE10290563D2/de
Application granted granted Critical
Publication of DE10290563D2 publication Critical patent/DE10290563D2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE10290563T 2001-02-22 2002-02-21 Mittel zur Hemmung von Tumorzellen Expired - Fee Related DE10290563D2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10290563T DE10290563D2 (de) 2001-02-22 2002-02-21 Mittel zur Hemmung von Tumorzellen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10109883 2001-02-22
DE10117266 2001-03-30
PCT/DE2002/000653 WO2002066027A1 (de) 2001-02-22 2002-02-21 Mittel zur hemmung von tumorzellen
DE10290563T DE10290563D2 (de) 2001-02-22 2002-02-21 Mittel zur Hemmung von Tumorzellen

Publications (1)

Publication Number Publication Date
DE10290563D2 true DE10290563D2 (de) 2004-04-29

Family

ID=26008653

Family Applications (4)

Application Number Title Priority Date Filing Date
DE10290563T Expired - Fee Related DE10290563D2 (de) 2001-02-22 2002-02-21 Mittel zur Hemmung von Tumorzellen
DE10207882A Withdrawn DE10207882A1 (de) 2001-02-22 2002-02-21 Mittel zur Hemmung von Tumorzellen
DE10290562T Expired - Fee Related DE10290562D2 (de) 2001-02-22 2002-02-21 Zielkomplex als Mittel zur Hemmung von Tumorzellen und zur Stimulierung der Angiogenese
DE10207881A Withdrawn DE10207881A1 (de) 2001-02-22 2002-02-21 Zielkomplex als Mittel zur Hemmung von Tumorzellen und zur Stimulierung der Angiogenese

Family Applications After (3)

Application Number Title Priority Date Filing Date
DE10207882A Withdrawn DE10207882A1 (de) 2001-02-22 2002-02-21 Mittel zur Hemmung von Tumorzellen
DE10290562T Expired - Fee Related DE10290562D2 (de) 2001-02-22 2002-02-21 Zielkomplex als Mittel zur Hemmung von Tumorzellen und zur Stimulierung der Angiogenese
DE10207881A Withdrawn DE10207881A1 (de) 2001-02-22 2002-02-21 Zielkomplex als Mittel zur Hemmung von Tumorzellen und zur Stimulierung der Angiogenese

Country Status (3)

Country Link
AU (1) AU2002252950A1 (de)
DE (4) DE10290563D2 (de)
WO (2) WO2002066027A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10147088A1 (de) * 2001-09-25 2003-04-17 Medinnova Ges Med Innovationen Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Erkrankungen, die mit Zellwachstumsstörungen einhergehen und Testsystem zum Auffinden solcher Wirksubstanzen
ES2245612B1 (es) * 2004-06-29 2007-08-16 Universidad De Barcelona Nuevo uso terapeutico del formoterol.
ITFI20050031A1 (it) * 2005-02-21 2006-08-22 Stefan Coccoloni Una composizione farmaceutica atta a prevenire l'invecchiamento e l'insorgere di malattie vascolari,neoplastiche,cutanee e dell'apparato pilifero
GB0625270D0 (en) * 2006-12-19 2007-01-31 Univ Leicester Angiogenesis
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003057D0 (sv) * 1990-09-26 1990-09-26 Astra Ab New process
US5135954A (en) * 1991-05-24 1992-08-04 The Regents Of The University Of California Use of formoterol for treatment of tissue injury

Also Published As

Publication number Publication date
AU2002252950A1 (en) 2002-09-04
DE10207882A1 (de) 2003-02-27
DE10290562D2 (de) 2004-04-29
WO2002066021A3 (de) 2002-10-31
WO2002066027A1 (de) 2002-08-29
WO2002066021A2 (de) 2002-08-29
DE10207881A1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
DE60130586D1 (de) Speicherzelle
DE60234125D1 (de) E inhibitoren
DK1474420T3 (da) Quinazolinforbindelser
PT1370553E (pt) Inibidores de rhoquinase
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
DE60210864D1 (de) Modifiziertes fluoreszentes Protein
NO20031562L (no) Vinterdekk
DK1440083T3 (da) Molekyler
NO20035573D0 (no) Kinazolinderivater
SE0301854L (sv) Antiigensättningsbehandling
DE10290563D2 (de) Mittel zur Hemmung von Tumorzellen
DE60114244D1 (de) Osteosynthesevorrichtung
DE60208650D1 (de) Laterales Leistungs-MOSFET
NO20024617D0 (no) Aryl- og heteroarylsulfonater
DE50308413D1 (de) Kontaktierung von nanoröhren
DE60219418T8 (de) Silanylphenole und -naphthole
DE60204723D1 (de) Plattenspieler
DE50301046D1 (de) Datenträgerkarte
ATA10792001A (de) Kompostiertrommel
ATE386726T1 (de) 3-aminocarbonyl substituierte benzoylpyrazolone
ATA9592001A (de) Geldbörse
UA4847S (uk) План міста
DE10393454D2 (de) Fluoreszierendes Protein
SE0100097D0 (sv) Tissue specific genes and their promotors - cell division
SE0104413D0 (sv) New protein

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee